EQRX wants to make high-end medicines less costly


A BIOTECH STARTUP wants to make me-too versions of existing drugs. So far, so familiar. Except that EQRx, a firm based in Boston, aims to launch ten high-end ... Read more

Bron: The Economist: Business
Geplaatst: 16 Jan 2020 - 17:35